Cargando…

Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma

BACKGROUND: Anti-interleukin (IL)-5/IL-5 receptor α (IL-5Ra) therapy has been shown to reduce maintenance oral corticosteroid (OCS) dose in severe eosinophilic asthma. However, the effect on cumulative OCS exposure is currently unknown. Neither is it known how prior OCS exposure affects response to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kroes, Johannes A., Zielhuis, Sybrand W.J., De Jong, Kim, Hashimoto, Simone, Sont, Jacob K., Zielhuis, Sander W., Van Roon, Eric N., Bel, Elisabeth H., Ten Brinke, Anneke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630606/ https://www.ncbi.nlm.nih.gov/pubmed/35595317 http://dx.doi.org/10.1183/13993003.02983-2021

Ejemplares similares

Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics
por: Kroes, Johannes A., et al.
Publicado: (2023)

Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report
por: Kroes, Johannes Anthon, et al.
Publicado: (2022)

Management of the patient with eosinophilic asthma: a new era begins
por: de Groot, Jantina C., et al.
Publicado: (2015)

Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
por: Kent, Brian D., et al.
Publicado: (2020)

Clinical profile of patients with adult-onset eosinophilic asthma
por: de Groot, Jantina C., et al.
Publicado: (2016)

Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future
por: Kroes, Johannes A., et al.
Publicado: (2022)

Pesticide exposure: the hormonal function of the female reproductive system disrupted?
por: Bretveld, Reini W, et al.
Publicado: (2006)

Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
por: Bagnasco, Diego, et al.
Publicado: (2017)

Levels of lead and other metals in human blood: suggestive relationships, determining factors.
por: Zielhuis, R L, et al.
Publicado: (1978)

Cumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis
por: Inoue, Yusuke, et al.
Publicado: (2015)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
por: Prazma, Charlene M., et al.
Publicado: (2019)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
por: Menzies-Gow, Andrew, et al.
Publicado: (2019)

The secular trends in male:female ratio at birth in postwar industrialized countries.
por: Jongbloet, P H, et al.
Publicado: (2001)

Patients to learn from: on the need for systematic integration of research and care in academic health care
por: Boeckhout, Martin, et al.
Publicado: (2017)

Transcriptional Regulation of the Human IL5RA Gene through Alternative Promoter Usage during Eosinophil Development
por: Laffey, Kimberly G., et al.
Publicado: (2021)

Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies
por: Casale, Thomas B., et al.
Publicado: (2022)

Corticosteroid-Sparing Effect of Chromoglycate Sodium and Nedocromil
por: Capristo, A. F., et al.
Publicado: (1994)

Eosinophils, beyond IL-5
por: Esnault, Stephane, et al.
Publicado: (2021)

The efficacy of corticosteroid‐sparing immunomodulatory therapy in treating patients with central multifocal choroiditis
por: de Groot, Evianne L., et al.
Publicado: (2020)

Plotselinge uitbraken
por: Bouter, L.M., et al.
Publicado: (2015)

The effect of a multifaceted empowerment strategy on decision making about the number of embryos transferred in in vitro fertilisation: randomised controlled trial
por: van Peperstraten, Arno, et al.
Publicado: (2010)

Cumulative dispensing of high oral corticosteroid doses for treating asthma in Australia
por: Hew, Mark, et al.
Publicado: (2020)

5. Certolizumab Pegol for RA in pregnancy
por: Thorne, Iona, et al.
Publicado: (2017)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
por: Basyigit, Ilknur, et al.
Publicado: (2004)

Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis
por: Rosenthal, David G., et al.
Publicado: (2019)

Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study
por: Menzies-Gow, Andrew, et al.
Publicado: (2022)

Inadequate quality of administration of intranasal corticosteroid sprays
por: Rollema, Corine, et al.
Publicado: (2019)

The Dutch Parelsnoer Institute Cerebrovascular Disease Initiative: a retrospective study of the effects of integrating clinical care and research on costs and quality of care in patients with ischaemic stroke
por: Mensing, Liselore A, et al.
Publicado: (2019)

Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial
por: van der Meer, Akke-Nynke, et al.
Publicado: (2021)

Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids
por: Mattsson, Gustav, et al.
Publicado: (2017)

Corticosteroid-sparing therapy: practice patterns among uveitis specialists
por: Esterberg, Elizabeth, et al.
Publicado: (2011)

Omalizumab as a corticosteroid‐sparing agent in the treatment of bullous pemphigoid
por: Vassallo, Camilla, et al.
Publicado: (2022)

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
por: Nanzer, Alexandra M., et al.
Publicado: (2020)

Excellent adherence and no contamination by physiotherapists involved in a randomized controlled trial on reactivation of COPD patients: a qualitative process evaluation study
por: Effing, Tanja W, et al.
Publicado: (2012)

Anti-IL5 Monoclonal Antibodies Reduce Asthma Exacerbations and Corticosteroids Dose in Three Eosinophilic Granulomatosis with Polyangiitis Case Reports
por: Skouvaklidou, Elpida, et al.
Publicado: (2023)

Reduced Local Response to Corticosteroids in Eosinophilic Chronic Rhinosinusitis with Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2020)

Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy
por: Eger, Katrien, et al.
Publicado: (2021)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma
por: Bilocca, David, et al.
Publicado: (2017)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_chubb2j124dvg9flvmttj49ut7